Surgepays Stock Analysis

The latest indifference towards the small price fluctuations of Surgepays created some momentum for shareholders as it was traded today as low as 0.0 and as high as 0.0 per share. The company executives did not add any value to Surgepays investors in December. However, most investors can still diversify their portfolios with Surgepays to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to shareholders with longer-term investment horizons.
Check out World Market Map.

Surgepays Stock Analysis 

The Surgepays stock analysis report makes it easy to digest most publicly released information about Surgepays and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Surgepays Stock analysis module also helps to analyze the Surgepays price relationship with some important fundamental indicators such as market cap and management efficiency.

Surgepays Stock Analysis Notes

The company recorded a loss per share of 3.39. Surgepays had not issued any dividends in recent years. The entity had a split on the 2nd of November 2021. SurgePays, Inc., through its subsidiaries, provides telecommunication services in the United States. The company was formerly known as Surge Holdings, Inc. and changed its name to SurgePays, Inc. in November 2020. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. To find out more about Surgepays contact Kevin Cox at 901 302 9587 or learn more at

Surgepays Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Surgepays' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgepays or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Surgepays is not yet fully synchronised with the market data
Surgepays has some characteristics of a very speculative penny stock
Surgepays has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company currently holds 10.92 M in liabilities with Debt to Equity (D/E) ratio of 244.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Surgepays has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 48.21 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 2.47 M.
Surgepays currently holds about 635.53 K in cash with (8.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.

Surgepays Upcoming and Recent Events

Earnings reports are used by Surgepays to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgepays previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report20th of October 2015
Next Earnings Report9th of December 2015
Next Fiscal Quarter End31st of July 2015
Next Fiscal Year End20th of October 2015
Last Quarter Report30th of April 2015
Last Earning Announcement31st of July 2014

Surgepays Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 36.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgepays's market, we take the total number of its shares issued and multiply it by Surgepays's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Surgepays Profitablity

Surgepays' profitability indicators refer to fundamental financial ratios that showcase Surgepays' ability to generate income relative to its revenue or operating costs. If, let's say, Surgepays is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Surgepays' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Surgepays' profitability requires more research than a typical breakdown of Surgepays' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (19.55) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (11.84) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.12.

Management Efficiency

The entity has return on total asset (ROA) of (43.79) % which means that it has lost $43.79 on every $100 spent on asset. This is way below average. Surgepays management efficiency ratios could be used to measure how well surgepays manages its routine affairs as well as how well it operates its assets and liabilities.

Surgepays Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Surgepays Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Surgepays to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Technical Analysis Now


Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module
Check out World Market Map. Note that the Surgepays information on this page should be used as a complementary analysis to other Surgepays' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Tools for Surgepays Stock

When running Surgepays price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years